子宫内膜癌手术时机对生存的影响
该研究基于美国国家癌症数据库2003至2012年成人子宫内膜癌数据,按低危和高危分层分析诊断至手术间隔对死亡率的影响。低危癌(N=140,078)和高危癌(N=68,360)中,诊断后第1、2周手术均与死亡率风险独立相关,且术后30天死亡率显著高于第3、4周手术者;低危癌诊断至手术>8周死亡率风险亦显著高于基线。作者建议诊断至治疗的目标间隔≤8周,但转诊至有经验的外科医生和充分的术前优化应优先于加快手术。
要点
- 低危子宫内膜癌诊断后第1周手术HR 1.4(95%CI 1.3-1.5),第2周手术HR 1.1(95%CI 1.0-1.2)。
- 高危子宫内膜癌诊断后第1周手术HR 1.5(95%CI 1.3-1.6),第2周手术HR 1.2(95%CI 1.1-1.2)。
- 低危癌诊断至手术>8周死亡率风险显著高于基线。
核心结论
- 子宫内膜癌诊断后前2周手术与围术期死亡率升高及低容量医院治疗相关,生存结局更差。
- 手术延迟仅对低危癌是死亡危险因素,可能与专科诊疗可及性差有关。
- 作者建议诊断至治疗的目标间隔≤8周,但转诊至有经验的外科医生和充分的术前优化应优先于加快手术。
研究设计与样本
- 查询美国国家癌症数据库2003年至2012年成人子宫内膜癌病例。
- 癌症分为低危(1或2级子宫内膜样组织学)和高危(非子宫内膜样和3级子宫内膜样组织学)并分别分析。
- 低危癌N=140,078,高危癌N=68,360。
- 计算诊断至手术间隔的未校正和校正死亡风险比,并对患者和医疗系统特征进行线性回归。
主要发现
- 低危癌诊断后第1周手术HR 1.4(95%CI 1.3-1.5),第2周手术HR 1.1(95%CI 1.0-1.2),均与死亡率风险独立相关。
- 低危癌诊断后第1或第2周手术者30天术后死亡率为0.7%,高于第3或第4周手术者的0.4%(P < .001)。
- 低危癌诊断至手术>8周时死亡率风险亦显著高于基线。
- 高危癌诊断后第1周手术HR 1.5(95%CI 1.3-1.6),第2周手术HR 1.2(95%CI 1.1-1.2),均与死亡率风险独立相关。
- 高危癌诊断后第1或第2周手术者30天术后死亡率为2.5%,高于第3或第4周手术者的1.0%(P < .001);诊断后第3周以后手术与校正死亡风险统计学显著增加无关。
关键数值与推荐
- 低危癌:诊断后第1周手术HR 1.4(95%CI 1.3-1.5),第2周手术HR 1.1(95%CI 1.0-1.2)。
- 高危癌:诊断后第1周手术HR 1.5(95%CI 1.3-1.6),第2周手术HR 1.2(95%CI 1.1-1.2)。
- 低危癌30天术后死亡率:第1或第2周手术0.7% vs 第3或第4周手术0.4%(P < .001)。
- 高危癌30天术后死亡率:第1或第2周手术2.5% vs 第3或第4周手术1.0%(P < .001)。
- 与手术时间增加至少1周独立相关的因素:黑人种族(1.1周;95%CI 0.9-1.4)、无保险(1.3周;95%CI 1.1-1.5)、医疗补助保险(1.7周;95%CI 1.5-1.9)、Charlson-Deyo合并症评分>1(1.0周;95%CI 0.8-1.2);高危癌中无保险(1.4周;95%CI 0.9-1.9)和医疗补助保险(1.4周;95%CI 1.1-1.7)。
临床怎么用
- 作者建议子宫内膜癌诊断至治疗的目标间隔≤8周。
- 作者建议转诊至有经验的外科医生和充分的术前优化应优先于加快手术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Optimal care for women with endometrial cancers often involves transfer of care from diagnosing physicians (eg, obstetrician-gynecologists) to treating physicians (eg, gynecologic oncologists.) It is critical to determine the effect of time to treatment on cancer outcomes to set best practices guidelines for referral processes. OBJECTIVE: We sought to determine the impact of time from diagnosis of endometrial cancer to surgical treatment on mortality and to characterize those patients who may be at highest risk for worsened survival related to surgical timing. STUDY DESIGN: The National Cancer Database was queried for incident endometrial cancers in adults from 2003 through 2012. Cancers were classified as low risk (grade 1 or 2 endometrioid histologies) or high risk (nonendometrioid and grade 3 endometrioid histologies) and analyzed separately. Demographic, clinicopathologic, and health system factors were collected. Unadjusted and adjusted hazard ratios for mortality were calculated by interval between diagnosis and surgery. Linear regression of patient and health care system characteristics was performed on diagnosis-to-surgery interval. RESULTS: For low-risk cancers (N = 140,078), surgery in the first and second weeks after diagnosis was independently associated with mortality risk (hazard ratio, 1.4; 95% confidence interval, 1.3-1.5; and hazard ratio, 1.1; 95% confidence interval, 1.0-1.2, respectively). The 30-day postoperative mortality was significantly higher among patients undergoing surgery in the first or second week postdiagnosis, compared to patients treated in the third or fourth week postdiagnosis (0.7% vs 0.4%; P < .001). Mortality risk was also significantly higher than baseline when time between diagnosis and surgery was >8 weeks. Independent associations with added time to surgery of at least 1 week were seen with black race (1.1 weeks; 95% confidence interval, 0.9-1.4), uninsurance (1.3 weeks; 95% confidence interval, 1.1-1.5), Medicaid insurance (1.7 weeks; 95% confidence interval, 1.5-1.9), and Charlson-Deyo comorbidity score >1 (1.0 weeks; 95% confidence interval, 0.8-1.2). For high-risk cancers (N = 68,360), surgery in the first and second weeks after diagnosis was independently associated with mortality risk (hazard ratio, 1.5; 95% confidence interval, 1.3-1.6; and hazard ratio, 1.2; 95% confidence interval, 1.1-1.2, respectively). The 30-day postoperative mortality was significantly higher among patients undergoing surgery in the first or second week postdiagnosis, compared to patients treated in the third or fourth week postdiagnosis (2.5% vs 1.0%; P < .001). Surgery after the third week postdiagnosis was not associated with a statistically significant increase in the adjusted risk of mortality. Independent associations with added time to surgery of at least 1 week were seen with uninsurance (1.4 weeks; 95% confidence interval, 0.9-1.9) and Medicaid insurance (1.4 weeks; 95% confidence interval, 1.1-1.7). CONCLUSION: Surgery in the first 2 weeks after diagnosis of endometrial cancer was associated with worsened survival associated with elevated perioperative mortality and treatment in low-volume hospitals. Delay in surgical treatment was a risk factor for mortality in low-risk cancers only and was likely associated with poor access to specialty care. We suggest that the target interval between diagnosis and treatment of endometrial cancers be ≤8 weeks; however, referral to an experienced surgeon and adequate preoperative optimization should be prioritized over expedited surgery.
引用
- Shalowitz DI, Epstein AJ, Buckingham L, et al. Survival implications of time to surgical treatment of endometrial cancers. Am J Obstet Gynecol. 2016. PMID: 27939327. doi:10.1016/j.ajog.2016.11.1050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。